Retention on anti-tumour necrosis factor therapy : the Waikato experience

Investigates the retention on anti-tumour necrosis factor (anti-TNF) agents used in a real-world setting. Performs a retrospective review of medical records of all patients commenced on anti-TNF therapy between 2006 and 2013 at the Rheumatology Department, Waikato Hospital, to obtain details of thei...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	New Zealand medical journal 2015-05, Vol.128 (1415), p.34-40
1. Verfasser:	Ip, Ken
Format:	Artikel
Sprache:	eng
Schlagworte:	Adalimumab Adolescent Adult Aged Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Antirheumatic agents Antirheumatic Agents - therapeutic use Arthritis, Juvenile - drug therapy Arthritis, Psoriatic - drug therapy Arthritis, Rheumatoid - drug therapy Biological response modifiers Child Cohort Studies Drug-Related Side Effects and Adverse Reactions Etanercept Female Humans Immunoglobulin G - therapeutic use Infliximab Kaplan-Meier Estimate Male Middle Aged Monoclonal antibodies New Zealand Patient Preference Receptors, Tumor Necrosis Factor - therapeutic use Retrospective Studies Spondylitis, Ankylosing - drug therapy Therapeutic use Treatment Failure Tumor necrosis factor Tumor Necrosis Factor-alpha - antagonists & inhibitors Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!